“www.LifeSciences.2023” at Genesis 2022 Featured Image

“www.LifeSciences.2023” at Genesis 2022

07 Dec 22

Who will be the stakeholders shaping and disrupting the sector in 2023 and beyond?
What – technologies, in R&D, drug delivery or related field will provide the best solutions for patients?
When will we see the impacts of the above take effect?

Facilitated by
Paul Branthwaite | Client Liaison | tranScrip

Laura Lane | VP – Venture Sciences (Europe) | Eli Lilly
David Roblin | CEO | Relation Therapeutics
Judit Molnar | Senior Partner, Early Development | tranScrip
Rowan Gardner | Co-Founder |PrecisionLife

Contact our team of experts

Our physicians, scientists and service experts can help to maximise the value of your products. Whatever your project requires, we have the people to meet your needs.